Verify Life Science LLC (CA, USA), health and life sciences company under Alphabet, recently announced its partnerships with four major pharmaceutical companies to allow them to move into the clinical trial market.
An isobaric labeling technique has been developed to amplify signals for comprehensive quantitative phosphoproteomic characterization of small cells populations.
Global leaders in life sciences and nonclinical drug development, Envigo (Huntingdon, UK) and LabCorp (NC, USA), have signed an innovative agreement in a bid to expand nonclinical drug development capabilities and create an independent research models provider.
Researchers have developed a novel technology to test for viral infections by detecting small amounts of antibodies in the blood.
Electron paramagnetic resonance has been used to measure in-cell distances between spin labels with higher sensitivity than previously seen for conversional methods.
Researchers have discovered a difference between radiation-sensitive and radiation-resistant tumors that could be utilized to assess tumor response, potentially sparing some patients of the toxic side effects of ineffective radiation therapy.
A new microfluidics device has been developed that could detect individual cancer cells in blood and has the potential to be used for liquid biopsies.